M. P. Semenov

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

SuperGen (United States)(Current)

Moscow State University of Medicine and Dentistry

Samara Regional Clinical Oncology Center

Peoples' Friendship University of Russia

Institute of Biomedical Chemistry

M. P. Semenov is an author at SuperGen (United States) specializing in clinical pharmacology, acute stroke management, and bolus-plus-infusion regimens.

ORCID

Publications per year

2022–2024

Publications

Nonimmunogenic staphylokinase in the treatment of acute ischemic stroke (FRIDA trial results)

M. Yu. Martynov, N. А. Shamalov, Е. B. Yarovaya et al. · S S Korsakov Journal of Neurology and Psychiatry · 2022 · 31 citations

Medicine, Neurology, Pharmacotherapy +17

Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPE

S Leontyev, Sergey Tereschenko, I. S. Yavelov et al. · Journal of Thrombosis and Haemostasis · 2024 · 15 citations

Medicine, Clinical Sciences, Surgery +14

Advanced results of Fortelyzin® use in the FRIDOM1 study and real clinical practice

D. V. Duplyakov, S. L. Konstantinov, G Klein et al. · Russian Journal of Cardiology · 2022 · 13 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +12

1–3 of 3